| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/09513590600629175 |
| P698 | PubMed publication ID | 16835078 |
| P2093 | author name string | Johannes C Huber | |
| Lukas A Hefler | |||
| Clemens B Tempfer | |||
| Christian Schneeberger | |||
| P2860 | cites work | Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease | Q22337234 |
| Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility | Q24679438 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Role of estrogen receptor-alpha in pharmacogenetics of estrogen action | Q28184284 | ||
| Evolutionary analyses of the human genome | Q28203271 | ||
| Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review | Q28248473 | ||
| Pharmacogenomics--drug disposition, drug targets, and side effects | Q34175616 | ||
| Associations between polymorphisms in the vitamin D receptor and breast cancer risk | Q34458272 | ||
| SNP alleles in human disease and evolution | Q35000193 | ||
| Population screening in the age of genomic medicine | Q35037759 | ||
| Oral Contraceptives and Inherited Thrombophilia: A Gene-Environment Interaction with a Risk of Venous Thrombosis? | Q35112752 | ||
| Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology | Q35610515 | ||
| Genotoxicity of steroidal estrogens | Q35820509 | ||
| Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis | Q44769974 | ||
| Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. | Q47228514 | ||
| P433 | issue | 3 | |
| P921 | main subject | single-nucleotide polymorphism | Q501128 |
| P304 | page(s) | 155-159 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Gynecological Endocrinology | Q5625187 |
| P1476 | title | How valid is single nucleotide polymorphism (SNP) diagnosis for the individual risk assessment of breast cancer? | |
| P478 | volume | 22 |
| Q40927138 | Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis |
| Q61446768 | Association between the insulin-like growth factor 1 gene rs2195239 and rs2162679 polymorphisms and cancer risk: a meta-analysis |
| Q37811317 | Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review |
| Q37861636 | Breast cancer prevention based on gene-environment interaction |
| Q36606068 | CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial |
| Q31159953 | Cluster analysis of genetic and epidemiological data in molecular epidemiology |
| Q36790428 | Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation |
| Q37662732 | Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis |
| Q50791604 | Insulin-like growth factor 1 gene polymorphism in women with breast cancer |
| Q35007775 | Murine Prkdc polymorphisms impact DNA-PKcs function |
| Q58775350 | The association between IGF1 gene rs1520220 polymorphism and cancer susceptibility: a meta-analysis based on 12,884 cases and 58,304 controls |
Search more.